TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

ERBB2 expression has been found in 19 to 44% of ovarian carcinomas; however, its predictive value has not been demonstrated, and trastuzumab has not found clinical application in ovarian cancer patients. We evaluated clinical significance of ERBB2 expression in relation to TP53 accumulation in ovari...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kupryjańczyk, J, Mądry, R, Plisiecka-Hałasa, J, Bar, J, Kraszewska, E, Ziółkowska, I, Timorek, A, Stelmachów, J, Emerich, J, Jędryka, M, Płużańska, A, Rzepka-Górska, I, Urbański, K, Zieliński, J, Markowska, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2004
Assuntos:
Molecular and Cellular Pathology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409772/
https://ncbi.nlm.nih.gov/pubmed/15545967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados